Report Update Nov 1, 2024

Northern America - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Northern America: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Northern America

In 2021, the North American medicaments containing insulin market was finally on the rise to reach $X for the first time since 2017, thus ending a three-year declining trend. Over the period under review, consumption, however, continues to indicate a deep reduction. The level of consumption peaked at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Northern America

In value terms, medicaments containing insulin production expanded to $X in 2021 estimated in export price. Overall, production, however, recorded a drastic downturn. The level of production peaked at $X in 2012; however, from 2013 to 2021, production stood at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports in Northern America

In 2021, after three years of growth, there was significant decline in shipments abroad of medicaments containing insulin but not antibiotics, when their volume decreased by -41.2% to X tons. In general, exports, however, posted a resilient expansion. The most prominent rate of growth was recorded in 2019 with an increase of 100% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2020, and then dropped dramatically in the following year.

In value terms, medicaments containing insulin exports reduced remarkably to $X in 2021. Over the period under review, exports saw a drastic downturn. The growth pace was the most rapid in 2018 with an increase of 81% against the previous year. The level of export peaked at $X in 2019; however, from 2020 to 2021, the exports remained at a lower figure.

Exports by Country

The biggest shipments were from the United States (X tons), together accounting for 99.9% of total export.

The United States was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of +13.1% from 2012 to 2021. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, the United States ($X) also remains the largest medicaments containing insulin supplier in Northern America.

From 2012 to 2021, the average annual growth rate of value in the United States amounted to -6.6%.

Export Prices by Country

The export price in Northern America stood at $X per ton in 2021, shrinking by -4.2% against the previous year. Over the period under review, the export price faced a deep downturn. The pace of growth was the most pronounced in 2016 an increase of 10% against the previous year. Over the period under review, the export prices reached the maximum at $X per ton in 2012; however, from 2013 to 2021, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for the United States.

From 2012 to 2021, the rate of growth in terms of prices for the United States amounted to -17.4% per year.

Medicaments Containing Insulin Imports

Imports in Northern America

In 2021, the amount of medicaments containing insulin but not antibiotics imported in Northern America contracted sharply to X tons, declining by -22.1% on the previous year. Over the period under review, imports recorded a deep contraction. The most prominent rate of growth was recorded in 2019 with an increase of 5,104% against the previous year. Over the period under review, imports hit record highs at X tons in 2013; however, from 2014 to 2021, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports dropped dramatically to $X in 2021. Overall, imports recorded a sharp decrease. The most prominent rate of growth was recorded in 2019 with an increase of 843% against the previous year. Over the period under review, imports attained the peak figure at $X in 2012; however, from 2013 to 2021, imports remained at a lower figure.

Imports by Country

Canada dominates imports structure, amounting to X tons, which was near 97% of total imports in 2021. The United States (X kg) followed a long way behind the leaders.

Canada was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of -5.0% from 2012 to 2021. The United States (-32.5%) illustrated a downward trend over the same period. From 2012 to 2021, the share of Canada increased by +35 percentage points.

In value terms, Canada ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Northern America, comprising 76% of total imports. The second position in the ranking was taken by the United States ($X), with a 22% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of value in Canada totaled -7.4%.

Import Prices by Country

In 2021, the import price in Northern America amounted to $X per ton, growing by 6.1% against the previous year. In general, the import price, however, showed a dramatic shrinkage. The growth pace was the most rapid in 2018 an increase of 449% against the previous year. The level of import peaked at $X per ton in 2012; however, from 2013 to 2021, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was the United States ($X per ton), while Canada amounted to $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Canada (-2.5%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in Northern America?

The U.S. remains the largest medicaments containing insulin consuming country in Northern America, comprising approx. 97% of total volume. It was followed by Canada, with a 2.5% share of total consumption.

What are the largest producers of medicaments containing insulin but not antibiotics in Northern America?

The U.S. constituted the country with the largest volume of medicaments containing insulin production, comprising approx. 100% of total volume.

What are the leading suppliers of medicaments containing insulin but not antibiotics in Northern America?

In value terms, the U.S. remains the largest medicaments containing insulin supplier in Northern America.

What are the leading importers of medicaments containing insulin but not antibiotics in Northern America?

In value terms, Canada constitutes the largest market for imported medicaments containing insulin but not antibiotics in Northern America, comprising 79% of total imports. The second position in the ranking was occupied by the U.S., with a 19% share of total imports.

What is the average export price for medicaments containing insulin but not antibiotics in Northern America?

In 2020, the medicaments containing insulin export price in Northern America amounted to $42,305 per ton, declining by -36.6% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in Northern America?

In 2020, the medicaments containing insulin import price in Northern America amounted to $23,787 per ton, surging by 44% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Northern America. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Bermuda
Canada
Greenland
Saint Pierre and Miquelon
United States

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Production in Northern America, split by region and country
Trade (exports and imports) in Northern America
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. CONSUMPTION BY COUNTRY
3. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
2. PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
11. COUNTRY PROFILES

The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO
- Bermuda
- Canada
- Greenland
- Saint Pierre and Miquelon
- United States
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption, By Country, 2018–2023
5. Production, In Physical Terms, By Country, 2012–2023
6. Imports, In Physical Terms, By Country, 2012–2023
7. Imports, In Value Terms, By Country, 2012–2023
8. Import Prices, By Country Of Destination, 2012–2023
9. Exports, In Physical Terms, By Country, 2012–2023
10. Exports, In Value Terms, By Country, 2012–2023
11. Export Prices, By Country Of Origin, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Consumption, By Country, 2023
4. Market Volume Forecast to 2030
5. Market Value Forecast to 2030
6. Products: Market Size And Growth, By Type
7. Products: Average Per Capita Consumption, By Type
8. Products: Exports And Growth, By Type
9. Products: Export Prices And Growth, By Type
10. Production Volume And Growth
11. Exports And Growth
12. Export Prices And Growth
13. Market Size And Growth
14. Per Capita Consumption
15. Imports And Growth
16. Import Prices
17. Production, In Physical Terms, 2012–2023
18. Production, In Value Terms, 2012–2023
19. Production, By Country, 2023
20. Production, In Physical Terms, By Country, 2012–2023
21. Imports, In Physical Terms, 2012–2023
22. Imports, In Value Terms, 2012–2023
23. Imports, In Physical Terms, By Country, 2023
24. Imports, In Physical Terms, By Country, 2012–2023
25. Imports, In Value Terms, By Country, 2012–2023
26. Import Prices, By Country, 2012–2023
27. Exports, In Physical Terms, 2012–2023
28. Exports, In Value Terms, 2012–2023
29. Exports, In Physical Terms, By Country, 2023
30. Exports, In Physical Terms, By Country, 2012–2023
31. Exports, In Value Terms, By Country, 2012–2023
32. Export Prices, 2012–2023